Log In
Print
BCIQ
Print
Print this Print this
 

Zoenasa Rectal Gel, Zoenasa Rectal Suspension

  Manage Alerts
Collapse Summary General Information
Company Altheus Therapeutics Inc.
DescriptionFixed-dose combination rectal gel of mesalamine (5-aminosalicylic acid) and N-acetylcysteine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat distal ulcerative colitis (UC); Treat pediatric ulcerative colitis (UC)
Regulatory Designation

U.S. - Orphan Drug (Treat pediatric ulcerative colitis (UC))

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today